The Cooper Companies, Inc. $COO Shares Acquired by TD Asset Management Inc

TD Asset Management Inc lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 17.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 804,609 shares of the medical device company’s stock after purchasing an additional 118,411 shares during the period. TD Asset Management Inc’s holdings in Cooper Companies were worth $57,256,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Horizon Investments LLC raised its holdings in shares of Cooper Companies by 5.0% in the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock valued at $241,000 after buying an additional 136 shares during the period. Axxcess Wealth Management LLC grew its position in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company’s stock valued at $623,000 after acquiring an additional 140 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in Cooper Companies by 16.3% during the first quarter. Exchange Traded Concepts LLC now owns 1,502 shares of the medical device company’s stock worth $127,000 after purchasing an additional 210 shares during the period. Wealth Alliance LLC lifted its position in shares of Cooper Companies by 5.5% during the first quarter. Wealth Alliance LLC now owns 4,059 shares of the medical device company’s stock worth $342,000 after purchasing an additional 210 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Cooper Companies by 3.5% in the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company’s stock valued at $550,000 after purchasing an additional 220 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

COO has been the topic of several recent research reports. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the stock a “sell” rating in a research note on Wednesday, October 1st. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, August 28th. Stifel Nicolaus cut their price target on Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Thursday, August 28th. Finally, BNP Paribas Exane raised Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price target on the stock in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $84.77.

Cooper Companies Stock Performance

NASDAQ:COO opened at $68.76 on Thursday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $109.04. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a market capitalization of $13.67 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.87 and a beta of 1.02. The business’s fifty day moving average price is $69.43 and its 200 day moving average price is $73.43.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has initiated a share repurchase program on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to buy up to 15.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s leadership believes its stock is undervalued.

Insider Activity at Cooper Companies

In related news, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction that occurred on Monday, September 29th. The stock was purchased at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the transaction, the director directly owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Albert G. White III acquired 10,000 shares of the company’s stock in a transaction on Friday, September 5th. The shares were purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the acquisition, the chief executive officer owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 17,975 shares of company stock valued at $1,216,346 in the last quarter. Company insiders own 1.98% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.